Single-inhaler triple versus dual bronchodilator therapy for GOLD group E and other exacerbating patients with COPD: real-world comparative effectiveness and safety

被引:5
|
作者
Suissa, Samy [1 ,2 ,3 ]
机构
[1] Jewish Gen Hosp, Lady Davis Inst, Ctr Clin Epidemiol, Montreal, PQ, Canada
[2] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada
[3] McGill Univ, Med, Montreal, PQ, Canada
关键词
D O I
10.1183/13993003.00883-2023
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Characteristics of COPD patients treated with single-inhaler triple therapy in real-life clinical practice
    Lassan, S.
    Keszegh, J.
    Lassanova, M.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2022, 123 (01): : 27 - 36
  • [32] THE IMPACT TRIAL: COST-EFFECTIVENESS ANALYSIS OF SINGLE-INHALER TRIPLE THERAPY (FF/UMEC/VI) VERSUS DUAL BRONCHODILATOR THERAPY (UMEC/VI) IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN SPAIN
    Vallejo-Aparicio, L. A.
    Paly, V. F.
    Schroeder, M.
    Martin, A.
    Risebrough, N.
    Abreu, C.
    Biswas, C.
    Izquierdo Alonso, J. L.
    Riesco Miranda, J. A.
    Soler Cataluna, J. J.
    Ismaila, A. S.
    VALUE IN HEALTH, 2019, 22 : S878 - S878
  • [33] Real-world characteristics of patients with asthma initiating fluticasone furoate/umeclidinium/vilanterol single-inhaler triple therapy in Japan
    Oga, Toru
    Mita, Chifuku
    Ito, Risako
    Requena, Gema
    Rothnie, Kieran J.
    Noorduyn, Stephen G.
    Yuanita, Liza
    Yarita, Masao
    RESPIRATORY INVESTIGATION, 2024, 62 (04) : 685 - 694
  • [34] Real-World Effectiveness of Fluticasone Furoate/ Umeclidinium/Vilanterol Once-Daily Single-Inhaler Triple Therapy for Symptomatic COPD: The ELLITHE Non-Interventional Trial
    Beeh, Kai -Michael
    Scheithe, Karl
    Schmutzler, Heike
    Krueger, Saskia
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2024, 19 : 205 - 216
  • [35] Real-World Study of Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol on Asthma Control in the US
    Bogart, Michael
    Germain, Guillaume
    Laliberte, Francois
    Mahendran, Malena
    Duh, Mei Sheng
    Dirocco, Kristi
    Noorduyn, Stephen G.
    Paczkowski, Rosirene
    Balkissoon, Ronald
    JOURNAL OF ASTHMA AND ALLERGY, 2023, 16 : 1309 - 1322
  • [36] Reduced exacerbations following switch from multiple-inhaler to once-daily single-inhaler triple therapy in COPD patients in a real-world primary care setting in England
    Rothnie, K.
    Wood, R.
    Czira, A.
    Banks, V.
    Camidge, L.
    Massey, O.
    Seif, M.
    Compton, C.
    Sharma, R.
    Ismaila, A.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [37] COST-EFFECTIVENESS ANALYSIS OF A SINGLE-INHALER TRIPLE THERAPY (TRELEGYA') VS DUAL COMBINATION AND MULTIPLE-INHALER TRIPLE THERAPY FOR THE TREATMENT OF PATIENTS WITH COPD MODERATE TO VERY-SEVERE
    Balmaceda, C.
    Abbott, T.
    Espinoza, M. A.
    VALUE IN HEALTH, 2020, 23 : S354 - S354
  • [38] The Use of Inflammation Parameters in the Care of Patients with Asthma Prescribed Extrafine Single-Inhaler Triple Therapy: A Real-World View from Germany
    Gessner, C.
    Akyildiz, B.
    Nachtigall, D.
    Nudo, E.
    Boeing, S.
    Timmermann, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [39] IMPACT Study: Cost-Effectiveness of Single-Inhaler Triple Therapy for the Treatment of COPD by Patients' Exacerbation History in Quebec
    Schroeder, M.
    Shah, D.
    Martin, A.
    Ndirangu, K.
    Risebrough, N.
    Ismaila, A. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [40] Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study
    Strange, Charlie
    Tkacz, Joseph
    Schinkel, Jill
    Lewing, Benjamin
    Agatep, Barnabie
    Swisher, Sean
    Patel, Sushma
    Edwards, Devechio
    Touchette, Daniel R.
    Portillo, Edward
    Feigler, Norbert
    Pollack, Michael
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2023, 18 : 2245 - 2256